US Stock MarketDetailed Quotes
KPTI Karyopharm Therapeutics
- 0.853
- -0.023-2.66%
Close Nov 27 16:00 ET
- 0.867
- +0.015+1.75%
Post 18:03 ET
106.83MMarket Cap-811P/E (TTM)
0.880High0.836Low366.74KVolume0.880Open0.876Pre Close313.13KTurnover0.32%Turnover RatioLossP/E (Static)125.31MShares1.95052wk High-0.67P/B96.99MFloat Cap0.61752wk Low--Dividend TTM113.77MShs Float49.005Historical High--Div YieldTTM5.04%Amplitude0.617Historical Low0.853Avg Price1Lot Size
Karyopharm Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -35.90%133.53M | -35.75%152.12M | -42.94%148.58M | -31.13%191.44M | -31.13%191.44M | 40.39%208.32M | 38.58%236.77M | 26.82%260.38M | 21.59%277.97M | 21.59%277.97M |
| -Cash and cash equivalents | 66.83%72.83M | 4.80%84.77M | -63.56%30.63M | -61.36%52.23M | -61.36%52.23M | -38.82%43.66M | -1.65%80.89M | -45.15%84.06M | -29.02%135.19M | -29.02%135.19M |
| -Short-term investments | -63.14%60.7M | -56.79%67.35M | -33.11%117.95M | -2.50%139.21M | -2.50%139.21M | 113.76%164.66M | 75.93%155.87M | 238.72%176.32M | 274.20%142.78M | 274.20%142.78M |
| Receivables | -16.20%31.78M | 17.70%38M | -11.70%31.08M | -42.74%26.96M | -42.74%26.96M | 38.17%37.92M | 37.48%32.28M | 40.85%35.2M | 109.30%47.09M | 109.30%47.09M |
| -Accounts receivable | -16.20%31.78M | 17.70%38M | -11.70%31.08M | -42.74%26.96M | -42.74%26.96M | 38.17%37.92M | 37.48%32.28M | 40.85%35.2M | 109.30%47.09M | 109.30%47.09M |
| Inventory | 50.47%4.67M | -5.34%3.48M | -27.65%2.77M | -27.96%3.04M | -27.96%3.04M | -26.92%3.11M | 5.82%3.67M | -1.21%3.83M | 2.87%4.22M | 2.87%4.22M |
| Restricted cash | -93.94%33K | -94.36%32K | -45.74%459K | -37.97%660K | -37.97%660K | -49.54%545K | -50.52%567K | -16.57%846K | -83.24%1.06M | -83.24%1.06M |
| Other current assets | 10.59%14.75M | -17.59%14.91M | -15.35%15.48M | -40.40%11.81M | -40.40%11.81M | -67.89%13.33M | -58.40%18.1M | -55.77%18.28M | 41.19%19.82M | 41.19%19.82M |
| Total current assets | -29.81%184.76M | -28.43%208.54M | -37.73%198.37M | -33.20%233.92M | -33.20%233.92M | 18.21%263.22M | 20.18%291.38M | 15.19%318.54M | 27.05%350.16M | 27.05%350.16M |
| Non current assets | ||||||||||
| Net PPE | -43.80%3.08M | -37.33%3.8M | -32.77%4.45M | -33.82%4.88M | -33.82%4.88M | -30.90%5.48M | -28.70%6.06M | -26.89%6.63M | -22.81%7.38M | -22.81%7.38M |
| -Gross PPE | -43.80%3.08M | -37.33%3.8M | -32.77%4.45M | -18.36%11.45M | -18.36%11.45M | -30.90%5.48M | -28.70%6.06M | -26.89%6.63M | -10.20%14.02M | -10.20%14.02M |
| -Accumulated depreciation | ---- | ---- | ---- | 1.20%-6.57M | 1.20%-6.57M | ---- | ---- | ---- | -9.71%-6.65M | -9.71%-6.65M |
| Other non current assets | 30.57%1.64M | 323.26%1.64M | 158.36%1.64M | 158.29%1.64M | 158.29%1.64M | 100.64%1.26M | -93.00%387K | -92.49%634K | -96.86%633K | -96.86%633K |
| Total non current assets | -29.93%4.72M | -15.69%5.44M | -16.08%6.09M | -18.64%6.52M | -18.64%6.52M | -21.28%6.74M | -54.04%6.45M | -58.52%7.26M | -73.03%8.01M | -73.03%8.01M |
| Total assets | -29.81%189.48M | -28.15%213.98M | -37.24%204.46M | -32.87%240.44M | -32.87%240.44M | 16.75%269.96M | 16.12%297.83M | 10.80%325.8M | 17.32%358.17M | 17.32%358.17M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | 513.26%5.78M | 22.30%2.8M | -44.41%5.03M | 12.62%3.12M | 12.62%3.12M | 15.99%943K | 35.01%2.29M | 162.94%9.05M | 72.99%2.77M | 72.99%2.77M |
| -accounts payable | 513.26%5.78M | 22.30%2.8M | -44.41%5.03M | 12.62%3.12M | 12.62%3.12M | 15.99%943K | 35.01%2.29M | 162.94%9.05M | 72.99%2.77M | 72.99%2.77M |
| Current accrued expenses | -10.07%50.11M | -3.86%49.81M | 16.62%54.85M | 15.71%44.88M | 15.71%44.88M | -0.01%55.71M | -8.09%51.81M | -19.43%47.03M | -21.53%38.79M | -21.53%38.79M |
| Current debt and capital lease obligation | 14.80%3.67M | 14.95%3.55M | 15.05%3.43M | 15.18%3.31M | 15.18%3.31M | 15.34%3.2M | 17.93%3.08M | 20.87%2.98M | 24.01%2.87M | 24.01%2.87M |
| -Current capital lease obligation | 14.80%3.67M | 14.95%3.55M | 15.05%3.43M | 15.18%3.31M | 15.18%3.31M | 15.34%3.2M | 17.93%3.08M | 20.87%2.98M | 24.01%2.87M | 24.01%2.87M |
| Other current liabilities | -13.06%1.94M | -16.07%1.47M | -18.55%2.04M | -10.50%1.65M | -10.50%1.65M | -9.50%2.23M | -6.22%1.75M | 21.23%2.5M | 172.57%1.85M | 172.57%1.85M |
| Current liabilities | -0.94%61.49M | -2.22%57.62M | 6.15%65.34M | 5.42%69.48M | 5.42%69.48M | 0.51%62.08M | -5.78%58.93M | -7.21%61.56M | -10.59%65.91M | -10.59%65.91M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | 9.30%190.59M | 9.77%192.09M | -1.48%173.01M | -1.42%173.71M | -1.42%173.71M | -1.35%174.37M | -1.29%175M | -1.22%175.62M | -1.16%176.2M | -1.16%176.2M |
| -Long term debt | 11.65%190.59M | 12.10%191.13M | 0.48%171.13M | 0.48%170.92M | 0.48%170.92M | 0.48%170.7M | 0.47%170.5M | 0.48%170.31M | 0.48%170.11M | 0.48%170.11M |
| -Long term capital lease obligation | --0 | -78.78%955K | -64.52%1.88M | -54.26%2.79M | -54.26%2.79M | -46.55%3.67M | -40.66%4.5M | -35.92%5.31M | -32.02%6.1M | -32.02%6.1M |
| Non current deferred liabilities | -44.52%73.5M | -44.62%73.5M | -0.18%132.48M | -0.18%132.48M | -0.18%132.48M | -0.39%132.48M | -0.21%132.72M | -0.21%132.72M | -0.21%132.72M | -0.21%132.72M |
| Derivative product liabilities | --17.36M | --18.63M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non current liabilities | 333.05%6.18M | 75.81%4.28M | 137.97%2.58M | --978K | --978K | --1.43M | --2.44M | --1.09M | ---- | ---- |
| Total non current liabilities | -6.70%287.63M | -6.98%288.5M | -0.44%308.07M | -0.57%307.17M | -0.57%307.17M | -0.48%308.28M | -0.04%310.15M | -0.44%309.42M | -0.75%308.92M | -0.75%308.92M |
| Total liabilities | -5.73%349.12M | -6.22%346.12M | 0.66%373.41M | 0.48%376.64M | 0.48%376.64M | -0.31%370.36M | -1.00%369.08M | -1.63%370.97M | -2.64%374.83M | -2.64%374.83M |
| Shareholders'equity | ||||||||||
| Share capital | 8.33%13K | 8.33%13K | 0.00%12K | 0.00%12K | 0.00%12K | 50.00%12K | 50.00%12K | 50.00%12K | 50.00%12K | 50.00%12K |
| -common stock | 8.33%13K | 8.33%13K | 0.00%12K | 0.00%12K | 0.00%12K | 50.00%12K | 50.00%12K | 50.00%12K | 50.00%12K | 50.00%12K |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | -6.05%-1.53B | -6.37%-1.5B | -10.62%-1.52B | -10.65%-1.49B | -10.65%-1.49B | -10.71%-1.45B | -11.16%-1.41B | -12.95%-1.38B | -14.02%-1.34B | -14.02%-1.34B |
| Paid-in capital | 2.06%1.37B | 2.15%1.37B | 1.70%1.36B | 1.74%1.35B | 1.74%1.35B | 15.41%1.35B | 16.21%1.34B | 17.28%1.33B | 20.85%1.33B | 20.85%1.33B |
| Gains losses not affecting retained earnings | 70.08%-222K | 22.73%-605K | -23.63%-518K | 74.76%-161K | 74.76%-161K | 1.33%-742K | -45.54%-783K | -581.61%-419K | -434.03%-638K | -434.03%-638K |
| Total stockholders'equity | -59.02%-159.65M | -85.46%-132.14M | -274.01%-168.96M | -717.76%-136.21M | -717.76%-136.21M | 28.43%-100.4M | 38.76%-71.25M | 45.63%-45.17M | 79.09%-16.66M | 79.09%-16.66M |
| Total equity | -59.02%-159.65M | -85.46%-132.14M | -274.01%-168.96M | -717.76%-136.21M | -717.76%-136.21M | 28.43%-100.4M | 38.76%-71.25M | 45.63%-45.17M | 79.09%-16.66M | 79.09%-16.66M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data